Selected
Type of publications
Regions
Countries
Diseases
Publication date
Target population
54 results found
2012 ∙ Cadeddu, C. De Waure, C. Gualano, M. R. Di Nardo, F. Ricciardi, W.
23-valent pneumococcal polysaccharide vaccine (PPV23) for the prevention of invasive pneumococcal diseases (IPDs) in the elderly: Is it really effective?
  • Efficacy/effectiveness
  • Older adults
  • Pneumococcal disease
Rating:
Critically low
2012 ∙ Chan, Z. C. Chan, T. S. Ng, K. K. Wong, M. L.
A systematic review of literature about women's knowledge and attitudes toward human papillomavirus (HPV) vaccination
  • Acceptance
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
Rating:
Not applicable
2012 ∙ Bechini, A. Tiscione, E. Boccalini, S. Levi, M. Bonanni, P.
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations
  • Efficacy/effectiveness
  • Administration
  • Newborn
  • Adolescents
  • Adults
  • Older adults
  • Pregnant women
  • Healthcare workers
  • Pertussis
Rating:
Critically low
2012 ∙ Hawken, J. Troy, S. B.
Adjuvants and inactivated polio vaccine: A systematic review
  • Administration
  • Efficacy/effectiveness
  • All age groups
  • Poliomyelitis
Rating:
Critically low
2012 ∙ Wiysonge, C. S. Ngcobo, N. J. Jeena, P. M. Madhi, S. A. Schoub, B. D. Hawkridge, A. Shey, M. S. Hussey, G. D.
Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews
  • Acceptance
  • Coverage
  • All age groups
  • South Africa
Rating:
Not applicable
2012 ∙ Agarwal, N. Ollington, K. Kaneshiro, M. Frenck, R. Melmed, G. Y.
Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review
  • Efficacy/effectiveness
  • All age groups
  • Influenza
  • Pneumococcal disease
  • Meningococcal disease
  • Hepatitis A
  • Hepatitis B
  • Tetanus
  • Pertussis
  • Varicella
  • Herpes zoster
Rating:
Critically low
2012 ∙ Pereira, J. A. Quach, S. Heidebrecht, C. L. Quan, S. D. Kolbe, F. Finkelstein, M. Kwong, J. C. Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network Vaccine Coverage Theme, Group
Barriers to the use of reminder/recall interventions for immunizations: a systematic review
  • Acceptance
  • Coverage
  • Healthcare workers
  • United States of America
Rating:
Not applicable
2012 ∙ El-Makhzangy, A. M. Ismail, N. M. Galal, S. B. Sobhy, T. S. Hegazy, A. A.
Can vaccination against pneumococci prevent otitis media with effusion?
  • Efficacy/effectiveness
  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
Rating:
Critically low
2012 ∙ Bar-On, E. S. Goldberg, E. Hellmann, S. Leibovici, L.
Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)
  • Efficacy/effectiveness
  • Safety
  • Administration
  • Newborn
  • Children
  • Diphtheria
  • Tetanus
  • Pertussis
  • Hepatitis B
  • Haemophilus influenzae type B
Rating:
High
2012 ∙ Ozawa, S. Mirelman, A. Stack, M. L. Walker, D. G. Levine, O. S.
Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review
  • Economic aspects
  • Low and Middle Income Countries
  • All age groups
Rating:
Not applicable